Skip to main content
Earnings Labs
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ·Healthcare·Biotechnology

$1.68

-2.33%

Mkt Cap $122.44M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (16 analysts)

$7.67

Range $5.00 – $10.00

Implied Upside

+356.5%

Consensus $7.67 vs current $1.68